NDC 70710-1688 – Fulvestrant
Fulvestrant 50 mg/mL · Injection, Solution · Intramuscular
Product NDC70710-1688
Product details
- Brand name
- Fulvestrant
- Generic name
- Fulvestrant
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- Injection, Solution
- Route
- Intramuscular
- Marketing category
- ANDA · ANDA215234
- Marketed since
- December 14, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Estrogen Receptor Antagonist
Active ingredients
- Fulvestrant 50 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70710-1688-8 | 2 SYRINGE, GLASS in 1 CARTON (70710-1688-8) / 5 mL in 1 SYRINGE, GLASS (70710-1688-2) | Dec 14, 2021 |
Recalls mentioning this NDC
- D-1351-2022 Aug 24, 2022 · Class II
Failed Impurities/Degradation Specifications
Other Fulvestrant products
- 70121-1463 Fulvestrant 250 mg/5mL · Injection, Solution · Amneal Pharmaceuticals LLC
- 70860-211 Fulvestrant 50 mg/mL · Injection, Solution · Athenex Pharmaceutical Division, LLC.
- 83634-203 Fulvestrant 50 mg/mL · Injection, Solution · Avenacy, Inc.
- 68001-484 Fulvestrant 250 mg/5mL · Injection, Solution · BluePoint Laboratories
- 43598-262 Fulvestrant 50 mg/mL · Injection, Solution · Dr.Reddy's Laboratories Inc
- 63323-715 Fulvestrant 50 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 16714-070 Fulvestrant 50 mg/mL · Injection, Solution · Northstar Rx, LLC,
- 25021-471 Fulvestrant 50 mg/mL · Injection, Solution · Sagent Pharmaceuticals
- 70700-284 Fulvestrant 50 mg/mL · Injection, Solution · Xiromed, LLC
- 70771-1626 Fulvestrant 50 mg/mL · Injection, Solution · Zydus Lifesciences Limited
- 16729-436 Fulvestrant 250 mg/5mL · Injection · Accord Healthcare Inc.
- 62332-650 Fulvestrant 50 mg/mL · Injection · Alembic Pharmaceuticals Inc.